Worry not, there may be a solution. If it's wallpaper, you may not need a new paint job. Different types of wallpaper can be removed with a few simple steps and at minimal cost. Whether it's ...

MASH and MASLD are prevalent, complex diseases often accompanied by metabolic comorbidities like obesity and diabetes. GLP-1 receptor agonists, such as semaglutide, show promise in resolving NASH ...

Inclusion of female and Hispanic/Latino patients has increased over time, but most trials of metabolic dysfunction-associated steatohepatitis (MASH) still take place in high-income countries and ...

Novo Nordisk's GLP-1 receptor agonist semaglutide has shown efficacy as a treatment for metabolic dysfunction-associated steatohepatitis (MASH) in a phase 3 trial, potentially teeing up US and ...